[1] |
World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
|
[2] |
中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 关于印发遏制结核病行动计划(2019—2022年)的通知. 国卫疾控发〔2019〕41号. 2019-05-31.
|
[3] |
中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02.
|
[4] |
中国疾病预防控制中心. 创建无结核社区行动方案(2022—2027 年)[EB/OL].[2024-08-31]. https://tb.chinacdc.cn/zgjhw/fzyw/guihua/202405/P020240516529342900427.pdf.
|
[5] |
徐彩红, 赵雁林. 中国结核病预防性治疗指南. 北京: 人民卫生出版社, 2023.
|
[6] |
Ni S, Wang J, Li X, et al. Assessment of health promotion action for tuberculosis of end tuberculosis action plan (2019—2022) in China. BMC Public Health, 2024, 24(1):2051. doi:10.1186/s12889-024-19413-w.
|
[7] |
Ferluga J, Yasmin H, Al-Ahdal MN, et al. Natural and trained innate immunity against Mycobacterium tuberculosis. Immunobiology, 2020, 225(3):151951. doi:10.1016/j.imbio.2020.151951.
|
[8] |
World Health Organization. Guidelines on the Management of Latent Tuberculosis Infection. Geneva: World Health Organization, 2015.
|
[9] |
Bekken GK, Ritz C, Selvam S, et al. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infect Dis, 2020, 20(1):96. doi:10.1186/s12879-020-4800-y.
pmid: 32005136
|
[10] |
中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委关于《中华人民共和国传染病防治法》(修订草案征求意见稿)公开征求意见的通知. 2022-10-02.
|
[11] |
Gao J, Zhang Y, Wang X, et al. Active screening for tuberculosis among high-risk populations in high-burden areas in Zhejiang province, China. Public Health, 2024, 226:138-143. doi:10.1016/j.puhe.2023.10.051.
pmid: 38056401
|
[12] |
Liu K, Peng Y, Zhou Q, et al. Assessment of active tuberculosis findings in the eastern area of China: A 3-year sequential screening study. Int J Infect Dis, 2019, 88:34-40. doi:10.1016/j.ijid.2019.07.029.
pmid: 31374346
|
[13] |
Sossen B, Richards AS, Heinsohn T, et al. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis. Lancet Respir Med, 2023, 11(4):367-379. doi:10.1016/S2213-2600(23)00097-8.
pmid: 36966795
|
[14] |
中国防痨协会结核病控制专业分会, 中国防痨协会老年结核病防治专业分会,《中国防痨杂志》编辑委员会. 中国社区肺结核主动筛查循证指南. 中国防痨杂志, 2022, 44(10): 987-997. doi:10.19982/j.issn.1000-6621.20220321.
|
[15] |
中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国教育部办公厅. 关于印发中国学校结核病防控指南的通知. 国卫办疾控函〔2020〕910号. 2020-10-16.
|
[16] |
World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention. Geneva:World Health Organization, 2020.
|
[17] |
Gao L, Li X, Liu J, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2017, 17(10):1053-1061. doi:10.1016/S1473-3099(17)30402-4.
pmid: 28716677
|
[18] |
Cui X, Gao L, Cao B. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries. Int J Infect Dis, 2020, 92S: S37-S40. doi:10.1016/j.ijid.2020.02.034.
|
[19] |
高磊, 金奇. 关口前移:再谈结核分枝杆菌潜伏感染管理和暴露后干预. 中国防痨杂志, 2021, 43(3):201-203. doi:10.3969/j.issn.1000-6621.2021.03.002.
|
[20] |
Cao X, Guo T, Xin H, et al. Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study. Eur J Clin Microbiol Infect Dis, 2024, 43(5):809-820. doi:10.1007/s10096-024-04777-z.
|
[21] |
Xin H, Cao X, Zhang H, et al. Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J, 2022, 60(1):2102359. doi:10.1183/13993003.02359-2021.
|
[22] |
Fei H, Yinyin X, Hui C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health West Pac, 2020, 3:100032. doi:10.1016/j.lanwpc.2020.100032.
|